Dystonia and reflex sympathetic dystrophy induced by ergotamine

A 59-year-old man developed dystonia and reflex sympathetic dystrophy after receiving high doses of ergotamine for migraine treatment. Ischemia is suggested as the precipitating factor.

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 6; no. 3; p. 263
Main Authors Merello, M J, Nogués, M A, Leiguarda, R C, López Saubidet, C
Format Journal Article
LanguageEnglish
Published United States 1991
Subjects
Dystonia - chemically induced
Dystonia - diagnosis
Dystonia - physiopathology
Ergotamine - administration & dosage
Ergotamine - adverse effects
Foot - physiopathology
Humans
Male
Middle Aged
Migraine Disorders - drug therapy
Reflex Sympathetic Dystrophy - chemically induced
Reflex Sympathetic Dystrophy - diagnosis
Reflex Sympathetic Dystrophy - physiopathology
Online AccessGet more information

Cover

More Information
Summary:A 59-year-old man developed dystonia and reflex sympathetic dystrophy after receiving high doses of ergotamine for migraine treatment. Ischemia is suggested as the precipitating factor.
ISSN:0885-3185
DOI:10.1002/mds.870060313